Russell Investments Group, Ltd. Intellia Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 198,510 shares of NTLA stock, worth $3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

198,510

Previous 150,578 31.83%

Holding current value

$3 Million

Previous $3.37 Million 21.07%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $945,219 - $1.31 Million	47,932 Added 31.83%	198,510 $4.08 Million
Q2 2024 Aug 08, 2024	BUY	$20.02 - $27.22 $807,506 - $1.1 Million	40,335 Added 36.59%	150,578 $3.37 Million
Q1 2024 May 08, 2024	SELL	$23.82 - $32.8 $22,891 - $31,520	-961 Reduced 0.86%	110,243 $3.03 Million
Q4 2023 Feb 05, 2024	SELL	$23.16 - $32.34 $372,019 - $519,477	-16,063 Reduced 12.62%	111,204 $3.39 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $876,822 - $1.27 Million	27,730 Added 27.86%	127,267 $4.02 Million
Q2 2023 Aug 10, 2023	SELL	$34.58 - $46.03 $374,466 - $498,458	-10,829 Reduced 9.81%	99,537 $4.06 Million
Q1 2023 May 09, 2023	BUY	$33.3 - $44.82 $1.13 Million - $1.52 Million	33,968 Added 44.46%	110,366 $4.11 Million
Q4 2022 Feb 08, 2023	SELL	$33.21 - $62.69 $198,230 - $374,196	-5,969 Reduced 7.25%	76,398 $2.67 Million
Q3 2022 Nov 04, 2022	SELL	$53.92 - $71.7 $1.69 Million - $2.25 Million	-31,359 Reduced 27.57%	82,367 $4.61 Million
Q2 2022 Jul 29, 2022	BUY	$38.49 - $76.21 $88,757 - $175,740	2,306 Added 2.07%	113,726 $5.89 Million
Q1 2022 May 05, 2022	BUY	$58.27 - $118.99 $2.01 Million - $4.11 Million	34,526 Added 44.9%	111,420 $8.1 Million
Q4 2021 Jan 21, 2022	BUY	$100.76 - $138.36 $4.41 Million - $6.06 Million	43,763 Added 132.09%	76,894 $9.09 Million
Q3 2021 Nov 08, 2021	BUY	$132.37 - $176.78 $679,587 - $907,588	5,134 Added 18.34%	33,131 $4.44 Million
Q2 2021 Aug 04, 2021	SELL	$60.88 - $161.91 $1.55 Million - $4.13 Million	-25,520 Reduced 47.69%	27,997 $4.53 Million
Q1 2021 May 10, 2021	SELL	$46.59 - $83.68 $1.59 Million - $2.85 Million	-34,056 Reduced 38.89%	53,517 $4.29 Million
Q4 2020 Feb 08, 2021	BUY	$18.83 - $63.53 $1.65 Million - $5.56 Million	87,573 New	87,573 $4.77 Million

Others Institutions Holding NTLA

# of Institutions

312

Shares Held

91.4M

Call Options Held

417K

Put Options Held

824K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.15B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Intellia Therapeutics, Inc. Transaction History